Andere Sprachen Bavarian Nordic A/S

Aktien

917165

DK0015998017

BAVA

Markt geschlossen - Nasdaq Copenhagen Andere Börsenplätze 16:59:38 16.05.2024			% 5 Tage	% 1. Jan.
173,4 ^DKK	+1,37 %		+4,62 %	-2,31 %

08.05.	Transcript : Bavarian Nordic A/S, Q1 2024 Earnings Call, May 08, 2024
08.05.	Bavarian Nordic A/S gibt Gewinnprognose für das Jahr 2024 ab	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations	08.05.
Bavarian Nordic A/S : Interim Results (Q1) as of 31 March 2024	08.05.
Bavarian Nordic Announces Interim Results for the First Three Months of 2024	08.05.
Bavarian Nordic A/S Provides Earnings Guidance for the Year 2024	08.05.
Bavarian Nordic A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	07.05.
Bavarian Nordic Books EUR65 Million Order for Smallpox Vaccine	30.04.
Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve	29.04.
Bavarian Nordic A/S Receives EUR 65 Million Contract to Supply Smallpox Vaccines for EU Strategic Reserve	29.04.
Bavarian Nordic Starts US Rolling Submission Process for Chikungunya Vaccine Candidate	29.04.
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate	29.04.
Bavarian Nordic A/S Initiates Rolling Submission of Biologics License Application with FDA for Chikungunya Vaccine Candidate	29.04.
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS	23.04.
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	22.04.
OPINIONES DE LOS ANALISTAS DEL DÍA : Acciona, LVMH, Endesa, Viscofan, Easyjet, Repsol, Unibail, Sika, Rio Tinto, Unicredit, ASML...	18.04.
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S	16.04.
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine	04.04.
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.	02.04.
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.	02.04.
Bavarian Nordic A/S : Notice Convening Annual General Meeting	21.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bavarian Nordic A/S

Aktien

917165

DK0015998017

BAVA

Andere Sprachen

Filter